Wishing you all the joys of the season! 
South & Central America PCR Technologies Market Forecast to 2030
South & Central America PCR Technologies Market Forecast to 2030 – Regional Analysis – by Technology (Real-Time PCR, Conventional PCR, Reverse Transcription PCR, Digital PCR, Multiplex RT PCR, Hot Start PCR, and Others), Offerings (Reagents & Consumables, Instruments, and Software & Services), Application (Gene Expression Analysis, Genetic Sequencing, Genotyping, Nucleic Acid Synthesis, Standard Validation, Point of Care Diagnostics, Environmental Application, and Others), and End User (Hospitals & Diagnostic Centers, Academia & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Advancements in PCR Technologies Fuel South & Central America PCR Technologies Market
The advantages of PCR such as exquisite sensitivity, relative simplicity, and cost-effectiveness have tremendously added to its popularity in the past years. The PCR technology has evolved significantly, resulting in more specific workflows for a wide variety of applications. The use of PCR technology is being explored into several nonconventional applications, making molecular diagnosis easier and faster. Advancements in dPCR and RT-PCR are used to diagnose diseases, identify viruses and bacteria, and aid forensic investigations. Researchers are trying to reduce test time using some nanomaterials. In March 2023, the Center for Augmented Safety System with Intelligence, Sensing of the Korea Institute of Science and Technology (KIST) announced the development of an ultrafast PCR technology. The development project was led by Dr. Sang Kyung Kim (Director) and Dr. Seungwon Jung’s research team. The ultrafast PCR reduces the test duration by 10 times compared to the previous tests by utilizing photothermal nanomaterials. The diagnostic performance of the new method is comparable to existing test methods, and it can be finished in 5 minutes.
A few of the technological advancements by companies in the PCR technologies market are as given, In March 2021, PCR Biosystems announced the launch of its IsoFast Bst polymerase reagents, which support sensitive, robust, and rapid amplification of RNA and DNA, enabling faster testing procedures. In October 2021, Thermo Fisher Scientific introduced the Applied Biosystem Quantstudio Absolute Q-Digital PCR System, the first fully integrated dPCR system designed to deliver highly accurate and consistent genetic analysis. The company claims that the product generates research results within 90 minutes. In May 2022, Bio-Rad Laboratories, Inc. introduced its CFX Duet Real-Time PCR System in selected countries that accept the CE Mark. The system is intended to support researchers in developing singleplex and duplex qPCR assays. In November 2022, PCR Biosystems launched new qPCR reagent mixes-Clara Probe Mix, Clara Probe 1-Step Mix, and Clara HRM Mix. In November 2022, Cepheid launched the Xpert Xpress MVP multiplex PCR test. The test helps detect DNA from organisms that are associated with three distinct conditions, namely, bacterial vaginosis (BV), trichomoniasis, and vulvovaginal candidiasis, from a single sample, aiding in more precise diagnosis and supporting accurate antibiotic treatment regimens. Thus, such advancements are expected to bring new trends into the PCR technologies market in the coming years.
South & Central America PCR Technologies Market Overview
The South & Central America PCR technologies market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil is estimated to hold the major share of the regional market during the forecast period. The increasing prevalence of cancer in Brazil drives the PCR technologies market growth in the country. Also, the aging population, increasing demand for advanced medical technologies, and the emerging biotech sector would create opportunities for the market in the coming years. Cancer is one of the major causes of mortality in Brazil. In the last few years, cancer cases have increased across the country. According to Revista Brasileira de Cancerologia, in 2023, Brazil had ~7.04 million new cancer cases. Further, PCR technologies are the major tools in the cancer diagnosis process; further technological advancements have enhanced the diagnosis. Also, the increasing incidences of yellow fever are a public health concern in Brazil. During the emerging coronavirus pandemic in Brazil, the country’s Health Ministry issued around a third of the 22.9 million available RT-PCR test kits. The federal government had provided 6.43 million real-time PCR assays for detecting SARS-CoV-2 to states. Further, Brazil has several players that are involved in the manufacturing of PCR tests. Therefore, the above-mentioned factors will likely contribute to the market growth during the forecast period.
South & Central America PCR Technologies Market Revenue and Forecast to 2030 (US$ Million)
South & Central America PCR Technologies Market Segmentation
The South & Central America PCR technologies market is segmented into technology, offerings, application, end user, and country.
Based on technology, the South & Central America PCR technologies market is segmented into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held the largest share of South & Central America PCR technologies market in 2022.
In terms of offerings, the South & Central America PCR technologies market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of South & Central America PCR technologies market in 2022. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR, and portable thermocyclers/PCR.
Based on application, the South & Central America PCR technologies market is segmented into gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held the largest share of South & Central America PCR technologies market in 2022.
Based on end user, the South & Central America PCR technologies market is segmented into hospitals & diagnostic centers, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centers segment held the largest share of South & Central America PCR technologies market in 2022.
By country, the South & Central America PCR technologies market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America PCR technologies market in 2022.
Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Takara Bio Inc, Standard Bio Tools Inc, and Ellume Ltd are some of the leading companies operating in the South & Central America PCR technologies market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team research, the South & Central America PCR technologies market was valued at US$ 684.37 million in 2022 and is expected to reach US$ 1,193.04 million by 2030, registering a CAGR of 7.2% from 2022 to 2030. Increasing demand for POC testing & surging investments and funds availability for PCR technologies are among the critical factors attributed to the South & Central America PCR technologies market expansion.
Point-of-care (POC) testing presents a significant opportunity for the PCR technology market by expanding its reach and applications. PCR technology, known for its accuracy and sensitivity, is increasingly being adapted for POC testing due to its ability to deliver rapid and reliable results at or near the point of care. As POC testing becomes more prevalent in healthcare settings such as clinics, emergency departments, and decentralized facilities, the demand for PCR platforms and assays tailored for POC applications is expected to rise. PCR’s advantages, including the ability to detect infectious diseases with high specificity and sensitivity, make it well-suited for POC testing, particularly in situations requiring rapid diagnosis and treatment decisions. Additionally, the miniaturization and automation of PCR systems further enable their integration into POC settings, facilitating on-site testing and improving patient care outcomes. As healthcare providers increasingly recognize the value of POC PCR testing in enhancing diagnostic capabilities and patient management, the market for POC PCR technologies is poised for growth and innovation.
On the contrary, high costs of PCR systems and availability of alternative assay hampers the growth of South & Central America PCR technologies market.
Based on technology, the South & Central America PCR technologies market is segmented into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held 37.9% share of South & Central America PCR technologies market in 2022, amassing US$ 259.34 million. It is projected to garner US$ 471.50 million by 2030 to expand at 7.8% CAGR during 2022-2030.
In terms of offerings, the South & Central America PCR technologies market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held 57.8% share of South & Central America PCR technologies market in 2022, amassing US$ 395.41 million. It is projected to garner US$ 728.13 million by 2030 to expand at 7.9% CAGR during 2022-2030. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR, and portable thermocyclers/PCR.
Based on application, the South & Central America PCR technologies market is segmented gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held 22.8% share of South & Central America PCR technologies market in 2022, amassing US$ 156.14 million. It is projected to garner US$ 288.78 million by 2030 to expand at 8.0% CAGR during 2022-2030.
Based on end user, the South & Central America PCR technologies market is segmented hospitals & diagnostic centers, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centers segment held 56.1% share of South & Central America PCR technologies market in 2022, amassing US$ 384.10 million. It is projected to garner US$ 690.39 million by 2030 to expand at 7.6% CAGR during 2022-2030.
By country, the South & Central America PCR technologies market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 58.7% share of South & Central America PCR technologies market in 2022. It was assessed at US$ 401.54 million in 2022 and is likely to hit US$ 720.83 million by 2030, exhibiting a CAGR of 7.6% during 2022-2030.
Key players operating in the South & Central America PCR technologies market are Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Takara Bio Inc, Standard Bio Tools Inc, and Ellume Ltd, among others.
In November 2023, Qiagen launched new kits for use on its QIAcuity systems and a major new software update designed to expand the portfolio of applications for use of digital PCR technology in areas like cell and gene therapies, DNA and RNA quantification, as well as food and pharmaceuticals safety.
o Highlights key business priorities to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in South & Central America PCR technologies market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America PCR Technologies Market – Key Industry Dynamics
4.1 PCR Technologies Market – Key Industry Dynamics
4.2 Market Drivers
4.2.1 Rising Prevalence of Genetic and Infectious Diseases
4.3 Market Restraints
4.3.1 High Costs of PCR Systems and Availability of Alternative Assays
4.4 Market Opportunities
4.4.1 Increasing Adoption of PCR Techniques in Emerging Countries
4.4.2 Increasing Demand for POC Testing
4.5 Future Trends
4.5.1 Advancements in PCR Technologies
4.6 Impact of Drivers and Restraints:
5. PCR Technologies Market – South & Central America Market Analysis
5.1 PCR Technologies Market Revenue (US$ Million), 2020 – 2030
6. South & Central America PCR Technologies Market Analysis – By Technology
6.1 Overview
6.2 Real Time PCR
6.2.1 Overview
6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Conventional PCR
6.3.1 Overview
6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Reverse Transcription PCR
6.4.1 Overview
6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.5 Digital PCR
6.5.1 Overview
6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.6 Multiplex RT PCR
6.6.1 Overview
6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.7 Hot Start PCR
6.7.1 Overview
6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.8 Others
6.8.1 Overview
6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
7. South & Central America PCR Technologies Market Analysis – By Offerings
7.1 Overview
7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
7.3 Reagents and Consumables
7.3.1 Overview
7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Reagents and Consumables
7.3.2.1.1 PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Vial Size
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Instruments
7.5 Software and Services
7.5.1 Overview
7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)
8. South & Central America PCR Technologies Market Analysis – By Application
8.1 Overview
8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Gene Expression Analysis
8.3.1 Overview
8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Genetic Sequencing
8.4.1 Overview
8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
8.5 Genotyping
8.5.1 Overview
8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
8.6 Nucleic Acid Synthesis
8.6.1 Overview
8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
8.7 Standard Validation
8.7.1 Overview
8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
8.8 Point of Care Diagnostics
8.8.1 Overview
8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
8.9 Environmental Application
8.9.1 Overview
8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
8.10 Others
8.10.1 Overview
8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
9. South & Central America PCR Technologies Market Analysis – By End User
9.1 Overview
9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals and Diagnostic Centers
9.3.1 Overview
9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
9.4 Academia and Research Institutes
9.4.1 Overview
9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
9.5 Pharmaceutical and Biotechnology Companies
9.5.1 Overview
9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
10. South & Central America PCR Technologies Market -Country Analysis
10.1 South & Central America: PCR Technologies Market
10.1.1 Overview
10.1.2 South & Central America PCR Technologies Market Revenue and Forecast and Analysis – By Country
10.1.2.1 Brazil
10.1.2.1.1 Overview
10.1.2.2 Brazil PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.2.1 Brazil PCR Technologies Market Breakdown by Technology
10.1.2.2.2 Brazil PCR Technologies Market Breakdown by Offerings
10.1.2.2.2.1 Brazil PCR Technologies Market Breakdown by Instruments
10.1.2.2.2.2 Brazil PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.2.2.2.1 Brazil PCR Technologies Market Breakdown by Vial Size
10.1.2.2.3 Brazil PCR Technologies Market Breakdown by Application
10.1.2.2.4 Brazil PCR Technologies Market Breakdown by End User
10.1.2.3 Argentina
10.1.2.3.1 Overview
10.1.2.4 Argentina PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.4.1 Argentina PCR Technologies Market Breakdown by Technology
10.1.2.4.2 Argentina PCR Technologies Market Breakdown by Offerings
10.1.2.4.2.1 Argentina PCR Technologies Market Breakdown by Instruments
10.1.2.4.2.2 Argentina PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.4.2.2.1 Argentina PCR Technologies Market Breakdown by Vial Size
10.1.2.4.3 Argentina PCR Technologies Market Breakdown by Application
10.1.2.4.4 Argentina PCR Technologies Market Breakdown by End User
10.1.2.5 Rest of South & Central America
10.1.2.5.1 Overview
10.1.2.6 Rest of South & Central America PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.6.1 Rest of South & Central America PCR Technologies Market Breakdown by Technology
10.1.2.6.2 Rest of South & Central America PCR Technologies Market Breakdown by Offerings
10.1.2.6.2.1 Rest of South & Central America PCR Technologies Market Breakdown by Instruments
10.1.2.6.2.2 Rest of South & Central America PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.6.2.2.1 Rest of South & Central America PCR Technologies Market Breakdown by Vial Size
10.1.2.6.3 Rest of South & Central America PCR Technologies Market Breakdown by Application
10.1.2.6.4 Rest of South & Central America PCR Technologies Market Breakdown by End User
11. PCR Technologies Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the PCR Technologies Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Thermo Fisher Scientific Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Promega Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN NV
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 bioMerieux SA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Hoffmann-La Roche Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Bio-Rad Laboratories Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Becton Dickinson and Co
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Takara Bio Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Standard Biotools Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Ellume Ltd
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the the Reporting Teams
13.2 Glossary of Terms
Table 1. PCR Technologies Market Segmentation
Table 2. PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Technology
Table 3. PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Offerings
Table 4. PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Reagents and Consumables
Table 5. PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Vial Size
Table 6. PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Instruments
Table 7. PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Application
Table 8. PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By End User
Table 9. Brazil PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Technology
Table 10. Brazil PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Offerings
Table 11. Brazil PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Instruments
Table 12. Brazil PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Reagents and Consumables
Table 13. Brazil PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Vial Size
Table 14. Brazil PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Application
Table 15. Brazil PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By End User
Table 16. Argentina PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Technology
Table 17. Argentina PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Offerings
Table 18. Argentina PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Instruments
Table 19. Argentina PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Reagents and Consumables
Table 20. Argentina PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Vial Size
Table 21. Argentina PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Application
Table 22. Argentina PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By End User
Table 23. Rest of South & Central America PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Technology
Table 24. Rest of South & Central America PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Offerings
Table 25. Rest of South & Central America PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Instruments
Table 26. Rest of South & Central America PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Reagents and Consumables
Table 27. Rest of South & Central America PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Vial Size
Table 28. Rest of South & Central America PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Application
Table 29. Rest of South & Central America PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By End User
Table 30. Recent Inorganic Growth Strategies in the PCR Technologies Market
Table 31. Recent Organic Growth Strategies in the PCR Technologies Market
Table 32. Glossary of Terms, PCR Technologies Market
Figure 1. PCR Technologies Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. PCR Technologies Market Revenue (US$ Million), 2020 – 2030
Figure 4. PCR Technologies Market Share (%) – By Technology, 2022 and 2030
Figure 5. Real Time PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Conventional PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Reverse Transcription PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Digital PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. Multiplex RT PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 10. Hot Start PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. PCR Technologies Market Share (%) – By Offerings, 2022 and 2030
Figure 13. Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Instruments Market Revenue and Forecasts to 2030 (US$ Million)
Figure 15. Software and Services Market Revenue and Forecasts to 2030 (US$ Million)
Figure 16. PCR Technologies Market Share (%) – By Application, 2022 and 2030
Figure 17. Gene Expression Analysis Market Revenue and Forecasts to 2030 (US$ Million)
Figure 18. Genetic Sequencing Market Revenue and Forecasts to 2030 (US$ Million)
Figure 19. Genotyping Market Revenue and Forecasts to 2030 (US$ Million)
Figure 20. Nucleic Acid Synthesis Market Revenue and Forecasts to 2030 (US$ Million)
Figure 21. Standard Validation Market Revenue and Forecasts to 2030 (US$ Million)
Figure 22. Point of Care Diagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 23. Environmental Application Market Revenue and Forecasts to 2030 (US$ Million)
Figure 24. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 25. PCR Technologies Market Share (%) – By End User, 2022 and 2030
Figure 26. Hospitals and Diagnostic Centers Market Revenue and Forecasts to 2030 (US$ Million)
Figure 27. Academia and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
Figure 28. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
Figure 29. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 30. South & Central America: PCR Technologies Market, by Key Country – Revenue (2022) (US$ Million)
Figure 31. South & Central America PCR Technologies Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 32. Brazil PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn)
Figure 33. Argentina PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn)
Figure 34. Rest of South & Central America PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn)
Figure 35. Growth Strategies in the PCR Technologies Market
The List of Companies – South & Central America PCR Technologies Market
1. Thermo Fisher Scientific Inc
2. Promega Corp
3. QIAGEN NV
4. bioMerieux SA
5. Hoffmann-La Roche Ltd
6. Bio-Rad Laboratories Inc
7. Becton Dickinson and Co
8. Takara Bio Inc
9. Standard BioTools Inc
10. Ellume Ltd
You must be logged in to post a review.
Reviews
There are no reviews yet.